Merck Oncology Overview ESMO 2016 Investor Presentation

Merck presented its oncology strategy and key clinical data at ESMO 2016, covering pipeline products, regulatory approvals, and commercial execution plans. The presentation outlines the company's oncology portfolio highlights and global launch initiatives discussed during the October 2016 investor call.